Medtronic (MDT) Cash from Investing Activities Growth (1y) (2015 - 2026)

Medtronic (MDT) Cash from Investing Activities Growth (1y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -4,224.26%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 95.53%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 3.20%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn -208.79%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -514.25%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn -397.90%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn -211.17%
10 Zimmer Biomet Holdings 17.27 Bn 16.86 Bn 1.51 Bn -50.00%

Historic Data

Download Data
DateValue
Jan 23, 2026 3.20%
Oct 24, 2025 -39.71%
Jul 25, 2025 -177.61%
Apr 25, 2025 29.60%
Jan 24, 2025 -19.24%
Oct 25, 2024 18.63%
Jul 26, 2024 51.95%
Apr 26, 2024 -46.53%
Jan 26, 2024 -146.34%
Oct 27, 2023 63.00%
Jul 28, 2023 65.99%
Apr 28, 2023 -275.28%
Jan 27, 2023 34.32%
Oct 28, 2022 -61.64%
Jul 29, 2022 -102.17%
Apr 29, 2022 -85.88%
Jan 28, 2022 84.24%
Oct 29, 2021 64.90%
Jul 30, 2021 -9,900.00%
Apr 30, 2021 425.75%